Hamps Bio Limited

Hamps Bio Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Hamps Bio Limited

₹ 21.2 -4.97%
29 Sep - close price
hampsbio.com BSE - SME: 544312
About

Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution[1]

Key Points

Business Overview:[1]
HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers.

Website BSE
  • Market Cap ₹ 18.5 Cr.
  • Current Price ₹ 21.2
  • High / Low ₹ 53.6 / 17.1
  • Stock P/E 61.6
  • Book Value ₹ 10.1
  • Dividend Yield 0.00 %
  • ROCE 6.68 %
  • ROE 4.94 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.1% over last 3 years.
  • Company might be capitalizing the interest cost
  • Working capital days have increased from 40.4 days to 124 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024 Sep 2024 Mar 2025
3.33 3.54 3.13
2.78 2.99 2.91
Operating Profit 0.55 0.55 0.22
OPM % 16.52% 15.54% 7.03%
0.02 0.08 0.07
Interest 0.06 0.08 0.06
Depreciation 0.20 0.19 0.19
Profit before tax 0.31 0.36 0.04
Tax % 25.81% 25.00% 25.00%
0.23 0.27 0.03
EPS in Rs 0.59 0.43 0.03
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
5.34 5.58 6.48 6.67
4.72 4.71 5.31 5.90
Operating Profit 0.62 0.87 1.17 0.77
OPM % 11.61% 15.59% 18.06% 11.54%
0.00 0.01 0.03 0.15
Interest 0.19 0.18 0.15 0.14
Depreciation 0.33 0.34 0.40 0.38
Profit before tax 0.10 0.36 0.65 0.40
Tax % -20.00% 0.00% 23.08% 25.00%
0.12 0.36 0.50 0.30
EPS in Rs 0.40 1.20 1.28 0.34
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 8%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 36%
TTM: -40%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 12%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1.50 1.50 1.96 4.36
Reserves -0.49 -0.14 1.38 4.44
2.04 1.74 1.05 2.97
0.60 0.86 0.73 0.97
Total Liabilities 3.65 3.96 5.12 12.74
2.15 2.61 2.52 2.43
CWIP 0.00 0.00 0.00 3.38
Investments 0.04 0.00 0.00 0.00
1.46 1.35 2.60 6.93
Total Assets 3.65 3.96 5.12 12.74

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.33 1.23 -0.29 -1.77
0.51 -0.75 -0.37 -6.20
-0.94 -0.48 0.67 8.00
Net Cash Flow -0.10 0.00 0.01 0.04

Ratios

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 47.16 49.71 55.76 65.12
Inventory Days 94.57 75.03 264.09 452.45
Days Payable 63.05 103.42 60.12 114.06
Cash Conversion Cycle 78.69 21.32 259.73 403.51
Working Capital Days -34.86 -58.22 55.20 124.22
ROCE % 17.56% 21.36% 6.68%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2024Mar 2025Sep 2025
71.99% 71.99% 72.00%
0.18% 0.00% 0.00%
0.05% 0.00% 0.00%
27.78% 28.01% 28.02%
No. of Shareholders 589410399

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports